Qiming Venture Partners has led a Series B round of nearly RMB100 million ($14 million) for Shanghai-based private hospital chain operator SinoUnited Health.
Matrix Partners India has made a full exit from Centre for Sight, operator of a chain of eye clinics in India, to Mahindra Partners after a holding period of nearly 10 years.
A group including CITIC Private Equity, CICC Capital and Baring Private Equity Asia has agreed to invest $1 billion in the healthcare unit of Chinese e-commerce giant JD.com, acquiring a combined stake of 14.5%.
MGI Tech, a Chinese manufacturer of equipment used in gene sequencing, has raised $200 million in funding led by Goldstone Investment, the PE arm under CITIC Securities, Green Pine Capital Partners and Orient Securities Capital Investment.
LeapFrog Investments has raised $700 million for its third fund with a view to investing in healthcare and financial services companies in emerging Asia and Africa. It initially targeted a corpus of $600 million.
Buy-and-build strategies, a mainstay of the PE toolkit in developed markets, are gaining exposure in emerging Asia’s healthcare sector. Proving a viable exit path will be the key to widespread adoption
Indian health and fitness start-up CureFit has raised $75 million from a group of investors including Accel Partners, Kalaari Capital, and Chiratae Ventures.
Australia’s BlueChilli has launched a health-tech accelerator in Singapore in cooperation with the local government as part of a broader pivot toward the region.
C-Bridge Capital has closed its third healthcare fund - which covers Asia but is most active in China - at $850 million, after increasing the hard cap. It is the largest dedicated healthcare vehicle raised for deployment in Asia by an independent private...
Asia Healthcare Holdings (AHH), a healthcare-focused operating and investment platform managed by TPG Growth, has agreed to acquire Nova IVI Fertility, an operator of in vitro fertilization (IVF) clinics based in India.
Sirnaomics, a China and US-based biopharmaceutical company specializing in gene therapeutics, has raised $47 million in Series C funding across two tranches.
Tot Biopharm, a private equity-backed Chinese cancer drug developer, has filed for a Hong Kong IPO under rules that allow for listings by pre-revenue biotech companies.
Healthcare-focused GTJA Investment Group has led a RMB300 million ($45 million) Series B round for Chinese online pharmacy operator Yao123.
The Blackstone Group has acquired Geo-Young, a South Korean wholesale drug distributor, working in conjunction with the founders. It facilitates an exit for local GP Anchor Equity Partners, which invested in the company in 2013.
SBI Ven Capital, a Singapore-based division of Japan’s SBI Group, has led a $17.2 million Series B round for Mfine, an Indian healthcare technology player that uses artificial intelligence (AI).
Panacea Venture, a Chinese GP founded by KPCB alumnus James Huang that specializes in early-stage healthcare investments, has closed its debut fund at approximately $180 million.
RHL Ventures has launched a MYR100 million ($24.2 million) fund focused on small to medium-sized enterprises (SME) with a cornerstone investment from government-owned SME Corp Malaysia.
TA Associates has acquired a significant minority stake in Indira IVF, an India-based provider of infertility services.
IDG Capital Partners and CDH Investments have led an RMB300 million ($45 million) Series B round for China-based Creative Biosciences, a manufacturer of testing kits for colon cancer.
Sequoia Capital China and HighLight Capital have led a $16 million Series A round for Cullgen, a biotech company that develops treatments for cancer by targeting previously “undruggable” cellular proteins.
As demand for private equity grows among institutional investors globally, HESTA is focusing on building its internal unlisted assets expertise to connect with potential fund managers on their own terms
Shiyu Capital, which focuses on growth-stage investments in Chinese healthcare companies, has closed its second renminbi-denominated fund at RMB3.2 billion ($477 million), beating the RMB3 billion target.
Everstone Group acquires Sahyadri Hospitals to serve as the seed asset for a planned national healthcare delivery strategy
Trusted Insight, a US-based syndicate of institutional investors focused on alternatives, has led a $16 million Series C round for Indian healthcare artificial intelligence (AI) company SigTuple.